| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/23/2003 | EP1303600A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/23/2003 | EP1303598A1 Molecular markers |
| 04/23/2003 | EP1303595A2 Cytochrome b5 gene and protein of candida tropicalis and methods relating thereto |
| 04/23/2003 | EP1303594A2 Glycosylated vegf-b and method for increasing the amount of soluble vegf-b |
| 04/23/2003 | EP1303592A1 Novel protein derived from agkistrodon saxatilis emelianov and process for preparing the same |
| 04/23/2003 | EP1303591A2 Masp-2, a complement-fixing enzyme, and uses for it |
| 04/23/2003 | EP1303587A2 Synchronised arabidopsis cell suspensions and uses thereof |
| 04/23/2003 | EP1303539A2 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY |
| 04/23/2003 | EP1303538A2 Ghrelin antagonists |
| 04/23/2003 | EP1303537A2 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 04/23/2003 | EP1303536A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 04/23/2003 | EP1303535A2 Protein complex serving as a vehicle for orally administerable medicaments |
| 04/23/2003 | EP1303534A2 Promyostatin peptides and methods of using same |
| 04/23/2003 | EP1303533A2 Chimeric peptide immunogens, their preparation and use |
| 04/23/2003 | EP1303532A2 Process to increase protein stability |
| 04/23/2003 | EP1303299A1 Compositions and methods for enhancing immunogenicity of antigens |
| 04/23/2003 | EP1303292A1 Chemokine conjugates |
| 04/23/2003 | EP1303287A1 Mhc peptides over-expressed on prostate cancer cells and methods of use |
| 04/23/2003 | EP1250055A4 Immune modulation with death receptor-induced apoptosis |
| 04/23/2003 | EP1235842A4 Rna interference pathway genes as tools for targeted genetic interference |
| 04/23/2003 | EP1190039A4 Gene encoding short integuments and uses thereof |
| 04/23/2003 | EP1117681B1 Rho-cocotoxin peptides having selective alpha-1 adrenoceptor activity |
| 04/23/2003 | EP1057033B1 Treating cancer |
| 04/23/2003 | EP1057032B1 Treating cancer |
| 04/23/2003 | EP1057031B1 Treating cancer |
| 04/23/2003 | EP1057030B1 Treating cancer |
| 04/23/2003 | EP1057029B1 Treating cancer |
| 04/23/2003 | EP1057028B1 Treating cancer |
| 04/23/2003 | EP1040351A4 C-terminal region of agouti-related transcript (art) protein |
| 04/23/2003 | EP1019503A4 Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides |
| 04/23/2003 | EP1016714B1 Novel plasmid dna containing reporter gene dna and use of the same |
| 04/23/2003 | EP1007558B1 Familial mediterranean fever gene |
| 04/23/2003 | EP0906571B1 Labelling and selection of molecules |
| 04/23/2003 | EP0861266B1 Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them |
| 04/23/2003 | EP0817858B1 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy |
| 04/23/2003 | EP0763982B1 Novel bioemulsifiers |
| 04/23/2003 | EP0672145B1 Interleukin-3 (il-3) multiple mutation polypeptides |
| 04/23/2003 | EP0669978B1 Flk-1 is a receptor for vascular endothelial growth factor |
| 04/23/2003 | EP0612348B1 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 04/23/2003 | EP0550599B1 Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus |
| 04/23/2003 | EP0546124B2 Multidomain hematopoiesis stimulators |
| 04/23/2003 | EP0483249B1 Method of transcriptionally modulating gene expression and of discovering chemicals capable of functioning as gene expression modulators |
| 04/23/2003 | CN1413257A Trans-species transfer of apoptotic genes and transgenic plants developed thereby |
| 04/23/2003 | CN1413251A Novel endoplasmic reticulum-localized protein, remedies containing the same for diseases associated with glycoprotein abnormality, DNA encoding this protein and gene remedies containing the same |
| 04/23/2003 | CN1413220A Anti-prostate stem cell antigen (PSCA) antibody compositions and method of use |
| 04/23/2003 | CN1413219A Molecular structure of RHD negative genes locus |
| 04/23/2003 | CN1413195A Immunoassay detection method for neonicotinyl insecticides |
| 04/23/2003 | CN1412308A Synthesis of calcitonin gene according to plant preference codon and its application in plant |
| 04/23/2003 | CN1412200A Method for preparing recombinant human bone morphogenetic protein-7 mature peptide dimer |
| 04/23/2003 | CN1412199A Wheat TaDREB, its code gene and method for culturing adverse-resistant plant |
| 04/23/2003 | CN1412198A Cell cycle regulatory protein |
| 04/23/2003 | CN1412181A Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
| 04/23/2003 | CN1106203C Chlamydia vaccine and process |
| 04/22/2003 | US6552246 Marker sequence has been substituted for at least intron 6 and exon 6, and wherein disruption prevents expression of CD45 on B-cells and T-cells and results in a decreased cytotoxic T-cell response |
| 04/22/2003 | US6552199 Fluorescence dyes and their use as fluorescence markers |
| 04/22/2003 | US6552181 Basal cell carcinoma tumor supressor gene |
| 04/22/2003 | US6552180 Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-2 and uses thereof |
| 04/22/2003 | US6552177 EH domain containing genes and proteins |
| 04/22/2003 | US6552173 Acellular red blood cell substitute |
| 04/22/2003 | US6552172 Forming water in oil emulsion of fibrinogen, thrombin and factor XIII, homogenizing and isolating |
| 04/22/2003 | US6552170 Derivatives of polyethylene glycol and related hydrophilic polymers and to polypeptides that have been covalently bonded to such active derivatives |
| 04/22/2003 | US6552169 Density enhanced protein tyrosine phosphatases |
| 04/22/2003 | US6552164 Reagents and methods useful for detecting diseases of the breast |
| 04/22/2003 | US6552016 For inhibiting aberrant growth states resulting from hedgehog gain- of-function, ptc loss-of-function or smoothened gain-of-function comprising contacting the cell with a hedgehog antagonist, such as a small molecule |
| 04/22/2003 | US6551996 Super-active porcine growth hormone releasing hormone analog |
| 04/22/2003 | US6551995 For allogenic or xenogenic implants and which act as a carrier of the osteogenic protein to induce new bone formation in mammals |
| 04/22/2003 | US6551994 For inhibiting cellular adhesion |
| 04/22/2003 | US6551991 Recombinant proteins derived from HGF and MSP |
| 04/22/2003 | US6551990 Methods of inhibiting ectopic calcification |
| 04/22/2003 | US6551830 Rh blood group antigen compositions and methods of use |
| 04/22/2003 | US6551825 PiggyBac transposon-based genetic transformation system for insects |
| 04/22/2003 | US6551824 Designation MVP-5180/91, deposited with the European Collection of Animal Cell Cultures under No V 920 92 318 |
| 04/22/2003 | US6551823 EBV-infected stomach cancer cell line |
| 04/22/2003 | US6551822 NL4 tie ligand homologue |
| 04/22/2003 | US6551821 Brain cyclic nucleotide gated ion channel and uses thereof |
| 04/22/2003 | US6551820 Transgenic plants capable of expressing immunogenic polypeptides, including hepatitis B antigen (HBsAg) in quantities sufficient to elicit an immune response in a human or animal that consumes all or a part of the plant |
| 04/22/2003 | US6551812 Diagnosing PPAR pathophysiologies, and identifying agents for treating these pathophysiologies, using nucleic acids whose expression changes following addition to cells of a ligand for PPAR |
| 04/22/2003 | US6551808 Desaturase antigen of Mycobacterium tuberculosis |
| 04/22/2003 | US6551807 Producing a ketocarotenoid in a host cell, by transfecting with nucleotide sequence for expression of carotenoid ketolase |
| 04/22/2003 | US6551801 Process for preparing purified dimer of bone-derived factor |
| 04/22/2003 | US6551800 Recombinant materials for production of a protein toxic to fire ants |
| 04/22/2003 | US6551799 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of pancreatic defects |
| 04/22/2003 | US6551796 Nucleic acid encoding urate transporter and methods of use thereof |
| 04/22/2003 | US6551795 Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics |
| 04/22/2003 | US6551794 Includes a protectant selected from a specified zwitterionic amino acid(s), trehalose, glycerol and ammonium sulphate, a buffer, and water soluble bulking agents; making fibrin; stabilized thrombin-like enzyme; sterility |
| 04/22/2003 | US6551793 Carotenoid-associated proteins CHRC and CHRD isolated from corollas of Cucumis sativus; nucleic acids encoding them |
| 04/22/2003 | US6551789 Process for characterizing a biological sample using patterns of oncogene expression |
| 04/22/2003 | US6551782 Patched genes and uses related thereto |
| 04/22/2003 | US6551781 Methods of screening for compounds that regulate the level of Nramp |
| 04/22/2003 | US6551775 Method to diagnose and treat pathological conditions resulting from deficient ion transport such as pseudohypoaldosteronism type-1 |
| 04/22/2003 | US6551773 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor |
| 04/22/2003 | US6551623 Immunomodulating compositions from bile |
| 04/22/2003 | US6551618 Compositions and methods for delivery of agents for neuronal regeneration and survival |
| 04/22/2003 | US6551597 Vaccine compositions for human papillomavirus |
| 04/22/2003 | US6551595 Smallpox inhibitor of complement enzymes (SPICE) protein and methods of inhibiting complement activation |
| 04/22/2003 | US6551593 Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through α 4 β 7 and its ligands and madcam |
| 04/22/2003 | US6551586 Merozoite surface antigen1 (MSA1); vaccinia virus expression vector which expresses a malaria MSA1 peptide in combination with a signal peptide and anchor peptide in a host animal |
| 04/22/2003 | US6551575 Methods for identifying compounds for motion sickness, vertigo and other disorders related to balance and the perception of gravity |
| 04/22/2003 | CA2253636C Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 04/22/2003 | CA2207741C Variants of human papilloma virus antigens |